In rats with myocardial infarction, interference by simvastatin with the TLR4 signal pathway attenuates ventricular remodelling

Abstract

Objective — The objective of this study was to investigate the effect of simvastatin on TLR4, TNF-a and IL-6 expression in the myocardium and its relation to left ventricular (LV) remodelling in a rat model of myocardial infarction (MI) and to investigate the mechanism by which simvastatin improves LV remodelling in rats after MIMethods and results— The rat MI models were established by ligation of the left anterior descending coronary artery and divided into three groups: (1) an untreated MI group; (2) a group treated with simvastatin [40 mg/(kg/d)] for 4 weeks; (3) the sham group.Cardiac geometry and function were determined by echocardiography and infarct size was determined by the histomorphometric analysis; the expression of TLR4 in the myocardium was measured by RT-PCR and western blotting;TNF-a and IL-6 levels in myocardial homogenate and serum were measured by ELISA. LVEDD and LVESD significantly increased and fractional shortening (FS) markedly decreased in the MI group. It was clear that simvastatin inhibited LV dilation and improved LV function after MI without affecting infarct size.The expression of TLR4, TNF-a and IL-6 in the myocardium significantly increased in the MI group and simvastatin markedly inhibits the expression of TLR4, TNF-a and IL-6 in the myocardium after MI.Serum TNF-a and IL-6 levels between the MI group and the simvastatin group remained unchanged. Both in the MI group and the simvastatin group, TLR4 protein positively related to LVEDD and to the levels of TNF-a and IL-6 in the myocardium, respectively.Conclusion— Amelioration of LV remodelling in rats after MI by simvastatin might be associated with its effect on the TLR4-mediated signalling pathway in the myocardium.